Ondine Biomedical Inc. (LON:OBI) Insider Carolyn Cross Buys 200,775 Shares

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross purchased 200,775 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was purchased at an average cost of GBX 12 ($0.15) per share, for a total transaction of £24,093 ($29,873.53).

Ondine Biomedical Price Performance

Ondine Biomedical stock opened at GBX 12.21 ($0.15) on Friday. The stock has a market cap of £33.86 million, a price-to-earnings ratio of -407.03 and a beta of 0.10. The company has a quick ratio of 8.26, a current ratio of 0.80 and a debt-to-equity ratio of 1,847.37. The business has a 50-day simple moving average of GBX 9.16 and a 200 day simple moving average of GBX 7.98. Ondine Biomedical Inc. has a 52 week low of GBX 4.50 ($0.06) and a 52 week high of GBX 13.30 ($0.16).

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.